The probiotic vsl#3® does not seem to be efficacious for the treatment of gastrointestinal symptomatology of patients with fibromyalgia: A randomized, double-blind, placebo-controlled clinical trial

  1. Calandre, E.P.
  2. Hidalgo-Tallon, J.
  3. Molina-Barea, R.
  4. Rico-Villademoros, F.
  5. Molina-Hidalgo, C.
  6. Garcia-Leiva, J.M.
  7. Carrillo-Izquierdo, M.D.
  8. Slim, M.
Journal:
Pharmaceuticals

ISSN: 1424-8247

Year of publication: 2021

Volume: 14

Issue: 10

Type: Article

DOI: 10.3390/PH14101063 GOOGLE SCHOLAR lock_openOpen access editor
Data source: Scopus